Theranos will begin publishing data about the company’s diagnostic tests -- potentially addressing one of the biggest criticisms of the high-profile, highly valued and intensely scrutinized company.
Company CEO Elizabeth Holmes made the announcement Monday during an on-stage conversation with Cleveland Clinic CEO Dr. Toby Cosgrove at the health system’s Medical Innovation Summit. Among the most severe critiques of Theranos is that it, unlike other life science businesses, has published little data to be reviewed by the medical community.
Read Full Article »